Alzheimer's Disease Expertise

Alzheimer's disease, a relentless neurodegenerative disorder that erodes memory and cognitive function, afflicts millions worldwide. At Southern Research, we are dedicated to providing comprehensive preclinical Alzheimer's disease services, empowering researchers like you to unravel the complexities of this disease and pave the way for life-altering therapies.


Demystifying Alzheimer's Disease

Your Partner in Preclinical Alzheimer's Disease Research and Testing

Our team of seasoned neuroscientists, neurologists, and molecular biologists possesses extensive experience in understanding the pathogenesis, progression, and potential therapeutic targets of Alzheimer’s disease. We are proficient in a variety of in vitro and in vivo Alzheimer’s disease assays, capable of evaluating the efficacy, safety, and pharmacokinetic properties of potential therapeutic compounds and cellular therapies.

Comprehensive Services Spanning the Alzheimer’s Disease Spectrum

We offer a comprehensive suite of preclinical Alzheimer’s disease services tailored to address the diverse challenges posed by this disease:

Neuroprotective and Disease-Modifying Compound Screening and Optimization: We utilize a range of in vitro and in vivo screening assays to identify promising neuroprotective and disease-modifying compounds, optimizing their potency, selectivity, and safety profile.

Pharmacokinetic and Pharmacodynamic (PK/PD) Studies: We determine the absorption, distribution, metabolism, and excretion (ADME) properties of potential therapeutic compounds, providing valuable insights into their pharmacokinetic profiles and pharmacodynamic effects in the central nervous system (CNS).

Regulatory Support and IND Preparation: We guide you through the intricate regulatory landscape, ensuring compliance with FDA guidelines and facilitating the preparation of Investigational New Drug (IND) applications.

The Power of Collaboration

Accelerating the Pace of Alzheimer's Disease Research

By partnering with Southern Research, you gain access to a wealth of expertise, resources, and infrastructure, enabling you to focus on your core competencies while we handle the complexities of preclinical Alzheimer’s disease research and testing. This strategic alliance empowers you to:

  1. Accelerate your research timelines and bring potential therapies closer to patients
  2. Enhance the efficiency and productivity of your research efforts
  3. Optimize resource allocation and cost-effectiveness through access to specialized expertise and infrastructure
  4. Ensure adherence to stringent regulatory standards and facilitate a smooth transition to clinical trials
  5. Mitigate the risk of project delays or failures through our rigorous preclinical testing and development process

Researching Alzheimer’s Disease Together

Contact us today to discuss your preclinical Alzheimer’s disease research and testing needs, and let us help you pave the way for a future free from this devastating disorder.

Basic Template Image